The US Food and Drug Administration has cleared Roche and partner Eli Lilly’s blood test to help identify signs of Alzheimer’s disease in people age ‌55 and older with cognitive decline. The test, ...
The test, Elecsys pTau217, is a biomarker blood test that can help doctors identify patients who are likely or unlikely to have Alzheimer's-related brain changes, Roche said on Monday. Sign up here.
http://www.bozemandailychronicle.com offers audio versions of articles using Instaread. Some words may be mispronounced. Eisai Co. and Biogen Inc.’s Alzhiemer’s ...
The tools for catching Alzheimer’s early on just got even sharper. On Thursday, the U.S. Food and Drug Administration cleared C2N Diagnostics’ PrecivityAD2 blood test for use in adults as young as 40 ...
Add Yahoo as a preferred source to see more of our stories on Google. The FDA clearance follows European ⁠approval for the test in May. - Sarah Silbiger/Getty Images/File The US Food and Drug ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd ...